Morningstar Investor users sign in here.

ARK Genomic Revolution ETF ARKG Strategy

The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.

ARK Genomic Revolution ETF News & Analysis

funds

No room on the ARK?

If performance turns for the worst, money that has been quick to come may be quicker yet to go, writes Morningstar's Ben Johnson.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,020.90 25.20 0.32%
CAC 40 8,239.99 14.20 0.17%
DAX 40 18,875.35 158.93 0.85%
Dow JONES (US) 39,796.68 238.57 0.60%
FTSE 100 8,445.80 17.67 0.21%
HKSE 19,073.71 41.35 -0.22%
NASDAQ 16,679.20 168.02 1.02%
Nikkei 225 38,385.73 29.67 0.08%
NZX 50 Index 11,525.88 92.21 -0.79%
S&P 500 5,291.33 44.65 0.85%
S&P/ASX 200 7,753.70 26.90 0.35%
SSE Composite Index 3,145.77 2.25 -0.07%

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.05 0.00 2.17%
Pantoro Ltd PNR 0.08 0.00 1.25%
Core Lithium Ltd CXO 0.15 0.01 -6.25%
Imugene Ltd IMU 0.07 0.00 -1.41%
Renascor Resources Ltd RNU 0.13 0.03 30.00%
Telstra Group Ltd TLS 3.67 0.02 0.55%
Arafura Rare Earths Ltd ARU 0.20 0.01 5.41%
South32 Ltd S32 3.67 0.05 1.38%
Karoon Energy Ltd KAR 1.88 0.03 -1.31%
Pilbara Minerals Ltd PLS 3.98 0.01 0.25%